Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
REalloys Inc
ALOY
$464M
| $738K | ﹤0.01% |
51,094
+36,422
| +248% | +$415K |
2026 Q1
1 quarter
|
|
5252
eGain
EGAN
$146M
| $737K | ﹤0.01% |
116,922
-56,884
| -33% | -$417K |
2016 Q1
41 quarters
|
|
5253
Natural Alternatives International
NAII
$7.02M
| $735K | ﹤0.01% |
307,630
+39,380
| +15% | +$103K |
2019 Q4
26 quarters
|
|
5254
NEOS S&P 500 High Income ETF
SPYI
$12.5B
| $734K | ﹤0.01% |
13,834
+6,534
| +90% | +$344K |
2023 Q4
10 quarters
|
|
5255
Starling Oncology
STLN
$704M
| $734K | ﹤0.01% |
135,085
-36,855
| -21% | -$155K |
2021 Q4
18 quarters
|
|
5256
RGC Resources
RGCO
$238M
| $733K | ﹤0.01% |
30,658
+2,250
| +8% | +$51.8K |
2013 Q2
52 quarters
|
|
5257
Claritev Corp
CTEV
$404M
| $732K | ﹤0.01% |
21,460
-75,595
| -78% | -$1.85M |
2020 Q2
24 quarters
|
|
5258
State Street SPDR S&P Kensho Future Security ETF
FITE
$150M
| $732K | ﹤0.01% |
6,512
-700
| -10% | -$71K |
2020 Q4
22 quarters
|
|
5259
Tuya Inc
TUYA
$1.05B
| $731K | ﹤0.01% |
415,172
-368,654
| -47% | -$803K |
2021 Q1
21 quarters
|
|
5260
Zhihu
ZH
$293M
| $729K | ﹤0.01% |
232,938
-81,995
| -26% | -$264K |
2021 Q2
20 quarters
|
|
5261
Alight
ALIT
$244M
| $728K | ﹤0.01% |
64,978
-38,980
| -37% | -$552K |
2021 Q3
19 quarters
|
|
5262
Lifeway Foods
LWAY
$336M
| $726K | ﹤0.01% |
24,340
-5,539
| -19% | -$141K |
2013 Q2
52 quarters
|
|
5263
Star Holdings Shares of Beneficial Interest
STHO
$96.8M
| $725K | ﹤0.01% |
79,413
-5,073
| -6% | -$43.8K |
2023 Q1
13 quarters
|
|
5264
VanEck Africa Index ETF
AFK
$95.8M
| $724K | ﹤0.01% |
28,177
-3,731
| -12% | -$101K |
2013 Q2
52 quarters
|
|
|
MGF
5265
Aberdeen Government Markets Income Fund
MGF
$88.1M
| $719K | ﹤0.01% |
50,112
+4,093
| +9% | +$59K |
2013 Q2
52 quarters
|
|
5266
Seaport Entertainment Group
SEG
$289M
| $719K | ﹤0.01% |
27,027
+11,493
| +74% | +$270K |
2024 Q3
7 quarters
|
|
5267
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$113M
| $718K | ﹤0.01% |
77,677
-17,153
| -18% | -$158K |
2013 Q2
52 quarters
|
|
5268
CytomX Therapeutics
CTMX
$525M
| $715K | ﹤0.01% |
190,799
-329,696
| -63% | -$1.26M |
2015 Q4
42 quarters
|
|
5269
Suncrete Inc
RMIX
$741M
| $715K | ﹤0.01% |
+31,719
| New | +$547K |
2026 Q2
0 quarters
|
|
5270
DELISTED
RE/MAX Holdings
RMAX
| $714K | ﹤0.01% |
72,444
-38,245
| -35% | -$334K |
2013 Q4
50 quarters
|
|
5271
Vinci Compass Investments Ltd
VINP
$719M
| $712K | ﹤0.01% |
73,154
+7,617
| +12% | +$79.1K |
2021 Q1
21 quarters
|
|
5272
Integra Resources
ITRG
$489M
| $710K | ﹤0.01% |
312,573
-1,594,667
| -84% | -$4.31M |
2024 Q2
8 quarters
|
|
5273
Aclaris Therapeutics
ACRS
$514M
| $709K | ﹤0.01% |
134,117
-2,612,185
| -95% | -$11.6M |
2016 Q2
40 quarters
|
|
5274
GoldMining Inc
GLDG
$170M
| $701K | ﹤0.01% |
773,161
+460,595
| +147% | +$515K |
2020 Q4
22 quarters
|
|
5275
AEye
LIDR
$40.8M
| $699K | ﹤0.01% |
485,219
-550,002
| -53% | -$993K |
2021 Q1
21 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.